CVS tops estimates and lifts 2026 outlook on Aetna strength

CVS 2026 – CVS beat first-quarter revenue and profit expectations and raised its 2026 guidance as Aetna’s insurance business continued improving.
CVS is signaling its turnaround is gaining traction, after the company topped first-quarter earnings and revenue expectations and lifted its outlook for 2026.
In its latest update. Misryoum reports that CVS increased full-year profit guidance to a range of $7.30 to $7.50 per share. up from prior expectations of $7.00 to $7.20.. The company also raised its 2026 revenue forecast to at least $405 billion. describing the shift as tied to favorable momentum in its insurance arm.
That insurance performance, driven by Aetna, appears to be the core reason investors are leaning in. With medical costs still a major pressure point for health insurers, results that suggest improving operations tend to draw outsized attention.
Meanwhile, CVS said all of its major segments exceeded revenue expectations, including its retail pharmacy and health services operations. The broader message is clear: the company’s plan to reset costs and improve execution is starting to show up in the numbers.
What’s especially notable in this round is the discussion around costs and predictability.. CVS has emphasized cutting expenses. closing underperforming stores. adjusting leadership. and tightening processes tied to privately run Medicare Advantage plans. alongside a continued effort to reduce costs in how care is managed.
Insight: Investors are watching not only whether CVS beats expectations, but whether it can keep doing so as medical expenses remain elevated across the insurance industry.
Looking more closely at Aetna. CVS reported first-quarter revenue of $35.97 billion. and the company pointed to improved efficiency from operational and technology changes.. Misryoum also notes that the insurer’s medical benefit ratio declined year over year. a movement that typically suggests premiums covered a larger share of expenses than before.
CVS added that medical costs have not fully normalized, but that its internal systems are helping it manage and forecast trends with fewer surprises. The company’s guidance increase reflects that confidence, while still keeping a cautious stance.
Insight: For consumers and employers, changes inside major insurers can eventually translate into how coverage and costs are managed, making each guidance update more than just a stock-market headline.